Abstract: Embodiments discussed herein facilitate generating a quantitative population atlas of tumor progression (TP) versus pseudo-progression (PsP) in Glioblastoma (GBM). A first set of embodiments discussed herein relates to generating a quantitative population atlas of TP versus PsP based on a plurality of multi-parametric (mpMRI) studies of a population of patients demonstrating GBM. A second set of embodiments discussed herein relates to computing a probability that a patient will experience PsP or TP based on a DICE analysis of a mapping of a diagnostic mpMRI study associated with the patient into the quantitative population atlas space.

Abstract: Embodiments discussed herein facilitate determination of one of a probability of prostate cancer recurrence-free survival or a risk factor associated with prostate cancer based on intra-tumor stromal morphology. Example embodiments can perform operations comprising: accessing a digitized histological image of a prostate of a patient, wherein the histological image comprises a region of interest associated with prostate cancer; identifying nuclei of intra-tumoral stromal cells within the region of interest; extracting, for the region of interest of the digitized histological image, one or more features describing the structure of the intra-tumoral stromal cells; and generating, via a model based at least on the one or more features, one of a probability of prostate cancer recurrence-free survival or a risk score associated with prostate cancer for the patient based at least on the extracted one or more features.

Abstract: Embodiments facilitate generating a biochemical recurrence (BCR) prognosis by accessing a digitized image of a region of tissue demonstrating prostate cancer (CaP) pathology associated with a patient; generating a set of segmented gland lumen by segmenting a plurality of gland lumen represented in the region of tissue using a deep learning segmentation model; generating a set of post-processed segmented gland lumen; extracting a set of quantitative histomorphometry (QH) features from the digitized image based, at least in part, on the set of post-processed segmented gland lumen; generating a feature vector based on the set of QH features; computing a histotyping risk score based on a weighted sum of the feature vector; generating a classification of the patient as BCR high-risk or BCR low-risk based on the histotyping risk score and a risk score threshold; generating a BCR prognosis based on the classification; and displaying the BCR prognosis.

Abstract: Embodiments discussed herein facilitate determination of responsiveness to chemoradiation treatment in rectal cancer patients based on structural deformation features obtained from a pre- or post-treatment medical imaging. One example embodiment can perform operations comprising: accessing an image volume of a rectum comprising a rectal tumor; generating a forward mapping based on non-rigidly registering a healthy rectal atlas to the image volume; inverting the forward mapping to generate an inverse mapping from the image volume to the healthy rectal atlas; determining, based on the inverse mapping, an associated deformation magnitude for each voxel of a plurality of voxels associated with the rectum; computing one or more structural deformation features based on the associated deformation magnitudes for the plurality of voxels; and predicting via a classifier whether or not the rectal tumor will respond to the chemoradiation treatment based at least in part on the one or more structural deformation features.

Abstract: Embodiments access a pre-neoadjuvant chemotherapy (NAC) radiological image of a region of tissue demonstrating breast cancer (BCa), the region of tissue including a tumoral region, the image having a plurality of pixels; extract a set of patches from the tumoral region; provide the set of patches to a convolutional neural network (CNN) configured to discriminate tissue that will experience pathological complete response (pCR) post-NAC from tissue that will not; receive, from the CNN, a pixel-level localized patch probability of pCR; compute a distribution of predictions across analyzed patches based on the pixel-level localized patch probability; classify the region of tissue as a responder or non-responder based on the distribution of predictions, and display the classification. Embodiments may further generate a probability mask based on the pixel-level localized patch probability; and generate a heatmap of likelihood of response to NAC based on the probability mask and the pre-NAC radiological image.

Abstract: Embodiments include controlling a processor to perform operations, the operations comprising: accessing a digitized image of a region of tissue demonstrating non-small cell lung cancer (NSCLC), detecting a member of a plurality of cellular nuclei represented in the image; classifying the member of the plurality of cellular nuclei as a tumor infiltrating lymphocyte (TIL) nucleus or non-TIL nucleus; extracting spatial TIL features from the plurality of cellular nuclei, including a first subset of features based on the spatial arrangement of TIL nuclei, and a second, different subset of features based on the spatial relationship between TIL nuclei and non-TIL nuclei; generating a set of graph interplay features based on the set of spatial TIL features; providing the set of graph interplay features to a machine learning classifier; receiving, from the machine learning classifier, a probability that the region of tissue will respond to immunotherapy, based, at least in part, on the set of graph interplay features;

Abstract: Embodiments access a radiological image of tissue having a tumoral volume and a peritumoral volume; define a vasculature associated with the tumoral volume; generate a Cartesian two-dimensional (2D) vessel network representation; compute a first set of localized Hough transforms based on the Cartesian 2D vessel network representation; generate a first aggregated set of peak orientations based on the first set of Hough transforms; generate a spherical 2D vessel network representation; compute a second set of localized Hough transforms based on the spherical 2D vessel network representation; generate a second aggregated set of peak orientations based on the second set of Hough transforms; generate a vascular network organization descriptor based on the aggregated peak orientations; compute a probability that the tissue is a member of a positive class based on the vascular network organization descriptor; classify the ROI based on the probability; and display the classification.

Abstract: Embodiments include accessing a set of digital pathology (DP) images having an imaging parameter; applying a low-computational cost histology quality control (HistoQC) pipeline to the DP images, where the low-computational cost HistoQC pipeline computes a first set of image metrics associated with a DP image, and assigns the DP image to a first or a second, different cohort based on the imaging parameter and the first set of image metrics; applying a first, higher-computational-cost HistoQC pipeline to a member of the first cohort; applying a second, different higher-computation-cost HistoQC pipeline to a member of the second cohort; where the first or second, higher-computational-cost HistoQC pipeline determines an artifact-free region of the member of the first or second cohort, respectively, and classifies the member of the first or second cohort, respectively, as suitable or unsuitable for downstream computation or diagnostic analysis based, at least in part, on the artifact free region.

Abstract: Embodiments predict early stage NSCLC recurrence, and include processors configured to access a pathology image of a region of tissue demonstrating early stage NSCLC; extract a set of pathomic features from the pathology image; access a radiological image of the region of tissue; extract a set of radiomic features from the radiological image; generate a combined feature set that includes at least one member of the set of pathomic features, and at least one member of the set of radiomic features; compute a probability that the region of tissue will experience NSCLC recurrence based, at least in part, on the combined feature set; and classify the region of tissue as recurrent or non-recurrent based, at least in part, on the probability. Embodiments may display the classification, or generate a personalized treatment plan based on the classification.

Abstract: Embodiments access a pre-immunotherapy image of tissue demonstrating NSCLC including a tumor and a peritumoral region; extract a first set of radiomic features from the image; provide the first set of radiomic features to a first machine learning classifier; receive a first probability from the first classifier that the tissue is hyperprogressor (HP) or non-responder (R); if the first probability that the tissue is within a threshold: generate a first classification of the ROT as HP or non-R based on the first probability; if the first probability is not within the threshold: extract a second set of radiomic features from the peritumoral region and provide the second set to a second machine learning classifier; receive a second probability from the second classifier that the tissue is HP or R; generate a second classification of the tissue as HP or R based on the second probability; and display the classification.

Abstract: Embodiments include apparatus for predicting cancer recurrence based on local co-occurrence of cell morphology (LoCoM). The apparatus includes image acquisition circuitry that identifies and segments at least one cellular nucleus represented in an image of a region of tissue demonstrating cancerous pathology; local nuclei graph (LNG) circuitry that constructs an LNG based on the at least one cellular nucleus, and computes a set of nuclear morphology features for a nucleus represented in the LNG; LoCoM circuitry that constructs a co-occurrence matrix based on the nuclear morphology features, computes a set of LoCoM features for the co-occurrence matrix, and computes a LoCoM signature for the image based on the set of LoCoM features; progression circuitry that generates a probability that the region of tissue will experience cancer progression based on the LoCoM signature, and classifies the region of tissue as a progressor or non-progressor based on the probability.

Abstract: Embodiments predict biochemical recurrence (BCR) or metastasis by accessing a set of images of a region of tissue demonstrating cancerous pathology, including a tumor region and a tumor adjacent benign (TAB) region, the set of images including a first stain type image, and a second stain type image; segmenting cellular nuclei represented in the first and second image; generating a combined feature set by extracting at least one feature from each of a tumor region and TAB region represented in the first image, and a tumor region and TAB region represented in the second image, providing the combined feature set to a machine learning classifier; receiving, from the classifier, a probability that the region of tissue will experience BCR or metastasis; and generating a classification of the region of tissue as likely to experience BCR or metastasis, or unlikely to experience BCR or metastasis.

Abstract: Embodiments include controlling a processor to perform operations for predicting biochemical recurrence (BCR) in prostate cancer (PCa), including accessing a first digitized pathology slide having a first stain channel of a region of tissue demonstrating PCa; accessing a second digitized pathology slide having a second, different stain channel of the region of tissue; extracting morphology features from the first stain channel; extracting stain intensity features from the second stain channel, where a stain intensity feature quantifies an amount of a molecular biomarker present in a cellular nucleus; controlling a first machine learning classifier to generate a first probability of BCR based on the morphology features; controlling a second machine learning classifier to generate a second, different probability of BCR based on the stain intensity features; computing an aggregate probability of BCR based on the first probability and the second probability; and displaying the aggregate probability.

Abstract: Embodiments discussed herein relate to accessing a digitized image associated with a patient of tissue demonstrating breast cancer pathology; segmenting a tumor region represented in the digitized image; segmenting collagen fibers represented in the tumor region; computing collagen vectors based on the segmented collagen fibers; generating an orientation co-occurrence matrix based on the collagen vectors; computing a collagen fiber orientation disorder feature based on the co-occurrence matrix; upon determining that the collagen fiber orientation feature exceeds a threshold value: generating a prognosis of the region of tissue as unlikely to experience breast cancer recurrence; upon determining that the collagen fiber orientation feature is less than or equal to the threshold value: generating a prognosis of the region of tissue as likely to experience breast cancer recurrence; classifying the patient as high-risk of recurrence or low-risk of recurrence based, at least in part, on the prognosis; and displayin

Abstract: Embodiments classify lung nodules by accessing a 3D radiological image of a region of tissue, the 3D image including a plurality of voxels and slices, a slice having a thickness; segmenting the nodule represented in the 3D image across contiguous slices, the nodule having a 3D volume and 3D interface, where the 3D interface includes an interface voxel; partitioning the 3D interface into a plurality of nested shells, a nested shell including a plurality of 2D slices, a 2D slice including a boundary pixel; extracting a set of intra-perinodular textural transition (Ipris) features from the 2D slices based on a normal of a boundary pixel of the 2D slices; providing the Ipris features to a machine learning classifier which computes a probability that the nodule is malignant, based, at least in part, on the set of Ipris features; and generating a classification of the nodule based on the probability.

Abstract: Methods and apparatus associated with predicting colorectal cancer tumor invasiveness are described. One example apparatus includes a set of circuits, and a data store that stores radiological images of tissue demonstrating colorectal cancer. The set of circuits includes a circumferential resection margin (CRM) prediction circuit that generates a CRM probability score for a diagnostic radiological image, an image acquisition circuit that acquires a diagnostic radiological image of a region of tissue demonstrating colorectal cancer pathology and that provides the diagnostic radiological image to the CRM prediction circuit, and a training circuit that trains the CRM prediction circuit to quantify chemoradiation response in the region of tissue represented in the diagnostic radiological image. The training circuit trains the CRM prediction circuit using a set of composite images.

Abstract: Embodiments access an image of a region of interest (ROI) demonstrating cancerous pathology; extract radiomic features from the ROI; define a radiomic feature expression scene based on the ROI and radiomic features; generate a cluster map by superpixel clustering the expression scene; generate an expression map by repartitioning the cluster map into expression levels; compute a textural and spatial phenotypes for the expression map based on the expression levels; construct a radiomic spatial textural (RADISTAT) descriptor by concatenating the textural and spatial phenotypes; provide the RADISTAT descriptor to a machine learning classifier; receive, from the machine learning classifier, a first probability that the ROI is a responder or non-responder, or a second probability that the ROI will experience long-term survival or short-term survival, based, at least in part, on the RADISTAT descriptor; and generate a classification of the ROI as a responder or non-responder, or long-term survivor or short-term surv

Abstract: Methods and apparatus quantify mass effect deformation in diagnostic images of patients demonstrating glioblastoma multiforme (GBM). One example apparatus includes an image acquisition circuit that acquires an image of a region of tissue demonstrating GBM pathology, a delineation circuit that segments a tumor region from the image, a pre-processing circuit that generates a pre-processed image by pre-processing the segmented image, a registration circuit that registers the pre-processed image with a template image of a healthy brain, a deformation quantification circuit that computes a set of differences between a position of a brain sub-structure represented in the registered image relative to the position of the brain sub-structure represented in the template image. Embodiments may include a classification circuit that classifies the region of tissue as a long or short-term survivor based, at least in part, on the set of differences.

Abstract: Embodiments predict prostate cancer (PCa) biochemical recurrence (BCR) employing an image acquisition circuit that accesses a pre-treatment image of a region of tissue demonstrating PCa; a segmentation circuit that segments a prostate capsule represented in the image; a registration circuit that registers the segmented prostate with a BCR? median template, and generates a registered surface of interest (SOI) mask by registering an SOI mask with the registered prostate; a mask circuit that generates a patient-specific SOI mask from the registered prostate and the registered SOI mask, and generates a patient-specific SOI mesh from the patient-specific SOI mask; a field effect induced organ distension (FOrge) circuit extracts a set of FOrge features from the patient-specific SOI mesh, and computes a probability that the region of tissue will experience BCR; and a classification circuit classifies the region of tissue as likely to experience BCR based on the probability.

Abstract: Embodiments discussed herein facilitate generating a quantitative population atlas of tumor progression (TP) versus pseudo-progression (PsP) in Glioblastoma (GBM). A first set of embodiments discussed herein relates to generating a quantitative population atlas of TP versus PsP based on a plurality of multi-parametric (mpMRI) studies of a population of patients demonstrating GBM. A second set of embodiments discussed herein relates to computing a probability that a patient will experience PsP or TP based on a DICE analysis of a mapping of a diagnostic mpMRI study associated with the patient into the quantitative population atlas space.